Rapid Etiological Classification of Meningitis by NMR Spectroscopy Based on Metabolite Profiles and Host Response

Bacterial meningitis is an acute disease with high mortality that is reduced by early treatment. Identification of the causative microorganism by culture is sensitive but slow. Large volumes of cerebrospinal fluid (CSF) are required to maximise sensitivity and establish a provisional diagnosis. We have utilised nuclear magnetic resonance (NMR) spectroscopy to rapidly characterise the biochemical profile of CSF from normal rats and animals with pneumococcal or cryptococcal meningitis. Use of a miniaturised capillary NMR system overcame limitations caused by small CSF volumes and low metabolite concentrations. The analysis of the complex NMR spectroscopic data by a supervised statistical classification strategy included major, minor and unidentified metabolites. Reproducible spectral profiles were generated within less than three minutes, and revealed differences in the relative amounts of glucose, lactate, citrate, amino acid residues, acetate and polyols in the three groups. Contributions from microbial metabolism and inflammatory cells were evident. The computerised statistical classification strategy is based on both major metabolites and minor, partially unidentified metabolites. This data analysis proved highly specific for diagnosis (100% specificity in the final validation set), provided those with visible blood contamination were excluded from analysis; 6–8% of samples were classified as indeterminate. This proof of principle study suggests that a rapid etiologic diagnosis of meningitis is possible without prior culture. The method can be fully automated and avoids delays due to processing and selective identification of specific pathogens that are inherent in DNA-based techniques.

[1]  R. Fishman Cerebrospinal Fluid in Diseases of the Nervous System , 1992 .

[2]  R. Mortishire-Smith,et al.  Metabolic profiling of rodent biological fluids via 1H NMR spectroscopy using a 1 mm microlitre probe. , 2002, The Analyst.

[3]  U. Himmelreich,et al.  Cryptococcomas distinguished from gliomas with MR spectroscopy: an experimental rat and cell culture study. , 2001, Radiology.

[4]  J. Selbig,et al.  Parallel analysis of transcript and metabolic profiles: a new approach in systems biology , 2003, EMBO reports.

[5]  J. E. Bennett,et al.  Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases , 2014 .

[6]  L. Mariey,et al.  Discrimination, classification, identification of microorganisms using FTIR spectroscopy and chemometrics , 2001 .

[7]  U. Himmelreich,et al.  NMR spectroscopic determination of microbiological profiles in infectious diseases. , 2004 .

[8]  W. Binder,et al.  Dexamethasone in adults with bacterial meningitis. , 2003, The New England journal of medicine.

[9]  J. Vion-Dury,et al.  CSF and serum metabolic profile of patients with Huntington's chorea: A study by high resolution proton NMR spectroscopy and HPLC , 1993, Neuroscience Letters.

[10]  James P. Malone,et al.  Comparative Proteomic Analysis of Intra- and Interindividual Variation in Human Cerebrospinal Fluid*S , 2005, Molecular & Cellular Proteomics.

[11]  Royston Goodacre,et al.  Metabolic footprinting as a tool for discriminating between brewing yeasts , 2007, Yeast.

[12]  Francisco Azuaje,et al.  Artificial Intelligence Methods And Tools For Systems Biology , 2004, Computational Biology.

[13]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .

[14]  P. Wright,et al.  Sensitivity improvement in proton-detected two-dimensional heteronuclear correlation NMR spectroscopy , 1991 .

[15]  Ian D. Wilson,et al.  HIGH RESOLUTION PROTON MAGNETIC RESONANCE SPECTROSCOPY OF BIOLOGICAL FLUIDS , 1989 .

[16]  D. Kell,et al.  A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations , 2001, Nature Biotechnology.

[17]  D. Desiderio,et al.  Human cerebrospinal fluid peptidomics. , 2005, Journal of mass spectrometry : JMS.

[18]  G. Pfyffer,et al.  Diagnostic performance of amplified Mycobacterium tuberculosis direct test with cerebrospinal fluid, other nonrespiratory, and respiratory specimens , 1996, Journal of clinical microbiology.

[19]  Julian L Griffin,et al.  Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: a pattern‐recognition 1H NMR study , 2005, NMR in biomedicine.

[20]  R. Somorjai,et al.  Distinguishing normal from rejecting renal allografts: application of a three—stage classification strategy to MR and IR spectra of urine , 2002 .

[21]  P. Peduzzi,et al.  Community-Acquired Bacterial Meningitis: Risk Stratification for Adverse Clinical Outcome and Effect of Antibiotic Timing , 1998, Annals of Internal Medicine.

[22]  P. Demirev,et al.  Characterization of intact microorganisms by MALDI mass spectrometry. , 2001, Mass spectrometry reviews.

[23]  I. Tominaga,et al.  Proton magnetic resonance spectroscopy of cerebrospinal fluid as an aid in neurological diagnosis. , 1994, Biological & pharmaceutical bulletin.

[24]  Jimmy D Bell,et al.  High resolution proton nuclear magnetic resonance studies of human cerebrospinal fluid. , 1987, Clinical science.

[25]  R L Somorjai,et al.  Near‐optimal region selection for feature space reduction: novel preprocessing methods for classifying MR spectra , 1998, NMR in biomedicine.

[26]  Daniel Marek,et al.  High-resolution capillary tube NMR. A miniaturized 5-microL high-sensitivity TXI probe for mass-limited samples, off-line LC NMR, and HT NMR. , 2002, Analytical chemistry.

[27]  D. Kell,et al.  High-throughput classification of yeast mutants for functional genomics using metabolic footprinting , 2003, Nature Biotechnology.

[28]  U. Himmelreich,et al.  Identification of metabolites of importance in the pathogenesis of pulmonary cryptococcoma using nuclear magnetic resonance spectroscopy. , 2003, Microbes and infection.

[29]  B. Dolenko,et al.  Identification of Staphylococcus aureus brain abscesses: rat and human studies with 1H MR spectroscopy. , 2005, Radiology.

[30]  R. Somorjai,et al.  Rapid Identification of Candida Species by Using Nuclear Magnetic Resonance Spectroscopy and a Statistical Classification Strategy , 2003, Applied and Environmental Microbiology.

[31]  P. Lewczuk,et al.  The amyloid-β (Aβ) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Aβ peptide , 2003 .

[32]  Muireann Coen,et al.  Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  Martijn Weisfelt,et al.  Clinical features and prognostic factors in adults with bacterial meningitis. , 2004, The New England journal of medicine.

[34]  Willem Boogerd,et al.  MALDI-TOF Mass Spectrometry Analysis of Cerebrospinal Fluid Tryptic Peptide Profiles to Diagnose Leptomeningeal Metastases in Patients with Breast Cancer* , 2005, Molecular & Cellular Proteomics.

[35]  W. Dunn,et al.  Measuring the metabolome: current analytical technologies. , 2005, The Analyst.

[36]  W. Wood,et al.  Acute meningitis. , 1947, The American journal of medicine.

[37]  J. Heitman Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases , 2000 .

[38]  D. Naumann,et al.  Identification of medically relevant microorganisms by vibrational spectroscopy. , 2002, Journal of microbiological methods.

[39]  Murray E. Alexander,et al.  A Data-Driven, Flexible Machine Learning Strategy for the Classification of Biomedical Data , 2004, Artificial Intelligence Methods And Tools For Systems Biology.

[40]  Katharina Buerger,et al.  Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease. , 2005, Combinatorial chemistry & high throughput screening.

[41]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .

[42]  A Heerschap,et al.  Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. , 1995, Clinical chemistry.

[43]  J. Vion-Dury,et al.  Experimental protocol for clinical analysis of cerebrospinal fluid by high resolution proton magnetic resonance spectroscopy. , 1998, Brain research. Brain research protocols.

[44]  Abhishek Gupta,et al.  Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children , 2005, NMR in biomedicine.

[45]  Cheng-Hsien Lu,et al.  Community-acquired bacterial meningitis in adults: the epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors , 2002, Clinical Neurology and Neurosurgery.